NCT06173037

RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: COMPLETED

Phase: PHASE2

Sponsor: RemeGen Co., Ltd.

Condition: Primary Peritoneal Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer

Signal summary

Public flags

Status signal: Low Signal

Timeline signals: None

Results signal: Completed No Results Found Signal

Operational burden: rare_population_signal | strict_eligibility_signal

Stopped reason

Context when available

No stop reason available in the current public record.